Background: Sarcopenia is a progressive loss of muscle strength and mass, highly prevalent among postmenopausal women. Early identification is critical, yet challenging in low-resource settings. This

Objective: To systematically review literature on the predictive value of masseter and psoas muscle sarcopenia in neurocritical patients. Design: Systematic Review. Subjects/Patients: Adults (≥ 18 yea